Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | JNJ-7706621 |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
JNJ-7706621 is a dual inhibitor of CDK1/2 and AURKA, B, which induces cell cycle arrest (PMID: 16204078, PMID: 31850205). |
| DrugClasses | Aurka Inhibitors 27 Aurkb Inhibitors 21 CDK1 Inhibitor 13 CDK2 Inhibitor 31 |
| CAS Registry Number | 443797-96-4 |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Fulvestrant + JNJ-7706621 | Fulvestrant JNJ-7706621 | 0 | 0 |
| JNJ-7706621 | JNJ-7706621 | 0 | 0 |